FI810637L - Anvaendning av hjaelpmedel som foerbaettrar absorptionen av laekemedel i produkter innehaollande beta-laktamantibioter - Google Patents

Anvaendning av hjaelpmedel som foerbaettrar absorptionen av laekemedel i produkter innehaollande beta-laktamantibioter

Info

Publication number
FI810637L
FI810637L FI810637A FI810637A FI810637L FI 810637 L FI810637 L FI 810637L FI 810637 A FI810637 A FI 810637A FI 810637 A FI810637 A FI 810637A FI 810637 L FI810637 L FI 810637L
Authority
FI
Finland
Prior art keywords
beta
laktamantibioter
hjaelpmedel
foerbaettrar
absorptionen
Prior art date
Application number
FI810637A
Other languages
English (en)
Finnish (fi)
Inventor
Takeru Higuchi
Toshiaki Nishihata
Original Assignee
Interx Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interx Research Corp filed Critical Interx Research Corp
Publication of FI810637L publication Critical patent/FI810637L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
FI810637A 1980-03-07 1981-02-27 Anvaendning av hjaelpmedel som foerbaettrar absorptionen av laekemedel i produkter innehaollande beta-laktamantibioter FI810637L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12809980A 1980-03-07 1980-03-07

Publications (1)

Publication Number Publication Date
FI810637L true FI810637L (fi) 1981-09-08

Family

ID=22433628

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810637A FI810637L (fi) 1980-03-07 1981-02-27 Anvaendning av hjaelpmedel som foerbaettrar absorptionen av laekemedel i produkter innehaollande beta-laktamantibioter

Country Status (11)

Country Link
EP (1) EP0036534B1 (de)
JP (1) JPS56128714A (de)
AT (1) ATE29837T1 (de)
DE (1) DE3176461D1 (de)
DK (1) DK101981A (de)
ES (1) ES8301107A1 (de)
FI (1) FI810637L (de)
GR (1) GR74441B (de)
IE (1) IE52973B1 (de)
NO (1) NO159767C (de)
PT (1) PT72616B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU541247B2 (en) * 1979-12-20 1985-01-03 R.P. Scherer Corporation Adjuvants for rectal delivery of drug substances
EP0177342A3 (de) * 1984-10-04 1987-12-02 Genentech, Inc. Orale Formulierungen therapeutischer Proteine
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
JPH05248655A (ja) * 1992-01-09 1993-09-24 Daikin Ind Ltd 空気調和装置
ATE171616T1 (de) * 1992-05-15 1998-10-15 Shiseido Co Ltd Äusserliches hautpräparat
US5424289A (en) * 1993-07-30 1995-06-13 Alza Corporation Solid formulations of therapeutic proteins for gastrointestinal delivery
FR2726468B1 (fr) 1994-11-03 1996-12-13 Oreal Utilisation de derive de l'acide salicylique comme stabilisant d'une emulsion huile-dans-eau
CA2275475A1 (en) * 1996-12-19 1998-06-25 Hiroshi Kikuchi Pharmaceutical composition for oral administration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1036194A (en) * 1962-03-26 1966-07-13 William Kurt Wallersteiner Improvements relating to antibiotic compositions
US3676434A (en) * 1970-07-29 1972-07-11 Lilly Co Eli Cephalosporin salts
US4210635A (en) * 1978-02-15 1980-07-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition

Also Published As

Publication number Publication date
NO810758L (no) 1981-09-08
ES500184A0 (es) 1982-12-01
NO159767B (no) 1988-10-31
GR74441B (de) 1984-06-28
EP0036534A1 (de) 1981-09-30
ES8301107A1 (es) 1982-12-01
IE810452L (en) 1981-09-07
JPS6346727B2 (de) 1988-09-19
NO159767C (no) 1989-02-08
ATE29837T1 (de) 1987-10-15
PT72616A (en) 1981-04-01
EP0036534B1 (de) 1987-09-23
DE3176461D1 (en) 1987-10-29
IE52973B1 (en) 1988-04-27
DK101981A (da) 1981-09-08
JPS56128714A (en) 1981-10-08
PT72616B (en) 1985-10-04

Similar Documents

Publication Publication Date Title
AU556734B2 (en) Oral absorption of polar bioactive agents
FI892016A (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, mahdollisesti -substituoitujen 4-(-kinolin-2-yyli-metoksi)-fenyylietikkahappojen ja -esterien valmistamiseksi
FI810637L (fi) Anvaendning av hjaelpmedel som foerbaettrar absorptionen av laekemedel i produkter innehaollande beta-laktamantibioter
SE8005714L (sv) Acetoximetyl-penamforeningar anvendbara som beta-laktamasinnibitorer
DK102081A (da) Adjuvans til antibiotikum
ATE9584T1 (de) Antibakterielle beta-lactam-verbindungen, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
FI884911A0 (fi) Laekemedel, i dessa saosom aktiva aemnen befintliga fosforin innehaollande 2-isoxazoliner och isoxazoler samt foerfarande foer framstaellning av dessa heterocykliska foereningar.
ES476259A1 (es) Un procedimiento para la preparacion de un compuesto.
SE8005309L (sv) Nya 5alfa-pregnan-20-ol-derivat och salter derav med syror, sett for framstellning samt anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
FI830192L (fi) Foerfarande foer framstaellning av penicillinderivat
IT1141970B (it) Antibiotico inibitore della beta-lattamesi e procedimento per la sua produzione

Legal Events

Date Code Title Description
FC Application refused

Owner name: INTERX RESEARCH CORPORATION